Privacy Policy
Signals Blog

Contributors

Categories

A prescription of hope

by | Aug 29, 2017

By Brian Sladek I am honoured to have my blog be just one of several covering this topic as part of Signal’s second annual blog carnival on the theme ‘Right to Try.’ Please click here to read what other bloggers think of this. As a patient, I don’t care about...

Right Turn: ‘Right to try’ state of affairs in U.S.

by | Aug 25, 2017

On Tuesday, August 29, Signals is hosting a blog carnival on the topic Right to Try. Before you read the perspectives of the contributing bloggers, here’s what President Trump thinks about the legislation and the Goldwater Institute’s reaction. It’s the Institute that...

BRM2017: State of the regenerative medicine industry

by | Aug 9, 2017

Although new to the field of science communication, Nathan Holwell has been involved in a variety of research during his undergraduate career and now in his graduate career. He has done research in drug delivery, gene delivery, biomaterials and diagnostic devices. His...

Reimbursement – the final frontier

by | Jul 6, 2017

Patrick Bedford is the Senior Manager of Clinical Translation and Regulatory Affairs at CCRM. He holds a Master’s Degree in Bioethics and Health Law, and a Regulatory Affairs Certificate. Patrick has spent over 11 years applying federal regulations to emerging...